Share on StockTwits
 

EXACT Sciences Corp. (NASDAQ:EXAS) CEO Kevin T. Conroy sold 8,708 shares of EXACT Sciences Corp. stock on the open market in a transaction dated Monday, February 24th. The stock was sold at an average price of $14.07, for a total value of $122,521.56. Following the completion of the transaction, the chief executive officer now directly owns 134,374 shares of the company’s stock, valued at approximately $1,890,642. The sale was disclosed in a document filed with the SEC, which is available at this link.

EXACT Sciences Corp. (NASDAQ:EXAS) traded up 0.29% during mid-day trading on Tuesday, hitting $14.00. 1,458,114 shares of the company’s stock traded hands. EXACT Sciences Corp. has a 52 week low of $6.93 and a 52 week high of $14.95. The stock’s 50-day moving average is $13.3 and its 200-day moving average is $12.16. The company’s market cap is $990.6 million.

EXACT Sciences Corp. (NASDAQ:EXAS) last posted its quarterly earnings results on Thursday, February 20th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.19) by $0.02. The company had revenue of $1.00 million for the quarter, compared to the consensus estimate of $1.02 million. Analysts expect that EXACT Sciences Corp. will post $-0.72 EPS for the current fiscal year.

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.